Regenerative medicine developer Elanix Biotechnologies said today it has raised $9.1 million (EU €7.8 million) with the opportunity to raise an additional $2.6 million (EU €2.1 million) through a private placement. The Germany-based company said that funds in the round are slated to support expanding its product portfolio, distribution and sales network and an e-commerce […]
Elanix
7 medtech stories we missed this week: Dec. 8, 2017
From Minimus Spine’s European distribution deal to Stimwave receiving FDA clearance, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Minimus Spine inks EU distribution deal Minimus Spine announced in a Dec. 4 press release that it has signed its first European distribution deal with Italian company Moss […]